Laboratoires Vivacy Revenue and Competitors

Paris, FRA

Location

N/A

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • Laboratoires Vivacy's estimated annual revenue is currently $127.6M per year.(i)
  • Laboratoires Vivacy's estimated revenue per employee is $476,119

Employee Data

  • Laboratoires Vivacy has 268 Employees.(i)
  • Laboratoires Vivacy grew their employee count by 46% last year.

Laboratoires Vivacy's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$36.2M957%N/AN/A
#2
$240.8M50614%N/AN/A
#3
$31.4M8237%N/AN/A
#4
$42.2M111-21%N/AN/A
#5
$2.9M1344%N/AN/A
#6
$127.6M26846%N/AN/A
#7
$9.7M3228%N/AN/A
#8
$17.3M5039%N/AN/A
#9
$1M50%N/AN/A
#10
$15M33030%N/AN/A
Add Company

What Is Laboratoires Vivacy?

Laboratories VIVACY is a French manufacturer specialising in the design, production and distribution of high quality injectable medical devices for use in the field of Anti-ageing, especially in Medical Aesthetics and Viscosupplementation.Founded in 2007 by specialists qualified in biopolymers and injectable product technologies with more than 25 years’ experience in the field, the company has acquired recognised expertise in dermal fillers based on hyaluronic acid and natural antioxidants, mannitol and sorbitol. The company has also created new technologies for use in ophthalmology (I.SPACE®), rheumatology (KARTILAGE®), gynecology (DESIRIAL®) and is currently developing in other medical viscosupplementation fields.Thanks to its strong international distribution network, Laboratoires VIVACY is present on the medical aesthetics market in over 80 countries. http://www.vivacy.eu/http://www.stylage.eu/http://www.desirial.eu/http://stylage-skinpro.com/

keywords:N/A

N/A

Total Funding

268

Number of Employees

$127.6M

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M268-3%N/A
#2
$35.4M268-10%N/A
#3
$42.7M26833%N/A
#4
$42.7M268-19%N/A
#5
$38.5M2696%N/A